Table 1.
Compound | ClogP a | IC50 b(nM) | IC50 Ratio Dd2/D6 | Cytotoxicity c(nM) | ||
---|---|---|---|---|---|---|
D6 (CQS) | Dd2 (CQR) | |||||
CQ | 5.1 | 7 | 102 | 15 | 12000 | |
1 | 8.9 | 3 | 5 | 1.7 | 700 | |
2 | 3.5 | 1.6 | 1.8 | 1.1 | 6500 | |
3 | 7.5 | 1.3 | 1.3 | 1.0 | 1100 | |
4 | 7.0 | 10 | 16 | 1.6 | 2200 | |
5 | 7.3 | 7 | 16 | 2.3 | N.D. | |
6 | 7.3 | 2 | 6 | 3.0 | N.D. | |
7 | 7.6 | 23 | 34 | 1.5 | 700 | |
8 | 7.4 | 8 | 11 | 1.4 | 1300 |
Evaluated using ChemDraw software.
Averages of at least 3 runs (± 15%). The uncertainties are estimated based on weighing uncertainties for the various compounds (which are free-bases and often oils), as well as on variability between determinations that were performed on different weeks.
Cytotoxicities are against mouse spleen lymphocytes. These values are estimated to be ±50%, based on weighing uncertainties for the various compounds (which are free-bases and often oils), as well as on variability between determinations that were performed on different weeks. N.D.: not determined.